|
| 37713135 | Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward. | Neuro Oncol | 2024 |
| 37526549 | Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). | Neuro Oncol | 2023 |
| 37610297 | You cannot diagnose what you cannot see: The importance of optimized imaging protocols for accurate disease staging and assessment. | Pediatr Blood Cancer | 2023 |
| 37091147 | Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks. | Front Oncol | 2023 |
| 37126770 | Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group. | J Clin Oncol | 2023 |
| 37440097 | Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience. | J Neurooncol | 2023 |
| 37534382 | Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors. | Pediatr Blood Cancer | 2023 |
| 34935967 | Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026). | Neuro Oncol | 2022 |
| 36033525 | Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. | Front Oncol | 2022 |
| 35552452 | Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry. | Neuro Oncol | 2022 |
| 35489353 | Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. | Lancet Oncol | 2022 |
| 35611273 | Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. | Neurooncol Adv | 2022 |
| 35859223 | Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. | | 2022 |
| 35664557 | Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data. | Neurooncol Adv | 2022 |
| 34347089 | Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report. | Neuro Oncol | 2022 |
| 33974582 | Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. | Journal of Pediatric Hematology/Oncology | 2022 |
| 34990779 | A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors. | Int J Radiat Oncol Biol Phys | 2022 |
| 35307742 | Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. | Neuro Oncol | 2022 |
| 34850169 | Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group study. | Neuro Oncol | 2022 |
| 34668975 | Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. | Neuro Oncol | 2022 |
| 35210278 | ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium. | | 2022 |
| 35148393 | Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. | Neuro Oncol | 2022 |
| 33431066 | A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. | Acta neuropathologica communications | 2021 |
| 34292305 | Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group. | JAMA Oncol | 2021 |
| 33539525 | OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes. | Neuro-Oncology | 2021 |
| 33585982 | Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1). | Acta Neuropathol | 2021 |
| 33631016 | A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. | Neuro Oncol | 2021 |
| 34110925 | Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma. | J Clin Oncol | 2021 |
| 33844469 | Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial. | Pediatr Blood Cancer | 2021 |
| 33502920 | Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. | J Clin Oncol | 2021 |
| 33502679 | Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. | Journal of Neuro-Oncology | 2021 |
| 33547201 | A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. | Clin Cancer Res | 2021 |
| 33025730 | Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial. | Pediatr Blood Cancer | 2021 |
| 32520842 | Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. | Journal of Pediatric Hematology/Oncology | 2021 |
| 33405376 | A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042). | Pediatr Blood Cancer | 2021 |
| 32502305 | cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. | Brain Pathol | 2020 |
| 32307792 | cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. | Brain Pathol | 2020 |
| 32009149 | A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. | Neuro Oncol | 2020 |
| 31774708 | Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221). | J Clin Oncol | 2020 |
| 32399739 | Molecular markers and targeted therapy in pediatric low-grade glioma. | Journal of Neuro-Oncology | 2020 |
| 32105509 | Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333. | J Clin Oncol | 2020 |
| 32393959 | Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report. | Neuro Oncol | 2020 |
| 33153497 | Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas. | Acta Neuropathol Commun | 2020 |
| 33034839 | A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). | J Neurooncol | 2020 |
| 32801164 | Diffuse Intrinsic Pontine Glioma Cells Are Vulnerable to Mitotic Abnormalities Associated with BMI-1 Modulation. | Molecular Cancer Research | 2020 |
| 32730180 | Reply to S.A. Upadhyaya. | J Clin Oncol | 2020 |
| 32506137 | MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. | Neuro Oncol | 2020 |
| 31545689 | Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study. | J Clin Oncol | 2019 |
| 30446898 | International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma. | J Neurooncol | 2019 |
| 30484110 | Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma. | J Neurooncol | 2019 |